Robert Markovich

Robert Markovich has extensive work experience in the pharmaceutical industry, with a focus on analytical development and characterization. Robert has held various senior director and executive director roles at companies such as Halozyme, Inc. and Nektar Therapeutics. In these positions, they have led analytical teams, developed product test methods, and supported regulatory filings. Prior to this, they worked as a principal consultant at RJM Pharma Consulting LLC. Robert also has experience at Merck & Co. Inc. and Schering-Plough Research Institute, where they led commercial and development analytical activities. Overall, Robert Markovich has a strong background in analytical development in the pharmaceutical industry.

Robert Markovich has a solid educational background starting from their studies at the Illinois Institute of Technology in 1982-1983, where they focused on physics and chemistry. Robert then attended Purdue University from 1983 to 1990, obtaining their Bachelor of Science degree in Chemistry with ACS approval. Continuing their studies at Purdue, Robert completed their Ph.D. in Industrial and Physical Pharmacy, specializing in Pharmaceutics, from 1986 to 1990. Following this, they were a Postdoctoral Research Assistant at Purdue University in the Department of Medicinal Chemistry/Pharmacognosy from 1990 to 1991.